Ajay Hinduja on the Future of CAR-T Therapy and Patient Care
- Fintechpulse
- Feb 3
- 1 min read
India has recently reached a significant milestone in its fight against cancer by successfully performing its first allogeneic CAR-T therapy. This accomplishment occurred at the P. D. Hinduja Hospital in Mumbai, led by the esteemed oncologist Dr. Vijay Patil. This advancement marks a transition from the treatment of blood cancers to the focus on solid tumors, featuring innovative technologies such as NexCar-19, developed by ImmunoACT.
In response to this landmark achievement, Ajay Hinduja, a member of the Hinduja Group Promoter Family, remarked, “The successful implementation of CAR-T therapy in India demonstrates our capability to utilize technology and local talent to create life-saving solutions. It also emphasizes the importance of ensuring that advanced treatments are accessible to those who need them.”
Comentários